Autopsy report · NCT02218775

FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study

“Funding for the study ended with one subject consented, but not randomized”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Andrew Krystal

Sponsor type

University, hospital or other

Conditions

Anxiety Disorders

Interventions

LY2456302

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Abuse Potential of Buprenorphine/Naloxone
  “Funding ended for the study” (71% match in meaning)
• Tracking Biomarkers of Speech Intelligibility
  “Funding for this study ended prior to enrollment of any participants due to a change in funding.” (70% match in meaning)
• Changes in Bone Turnover With Increased Incretin Hormone Exposure
  “Study closed by sponsor. Funding ended.” (70% match in meaning)
• Angiotensin 2 for Hepatorenal Syndrome
  “Funding issues; the study was never started” (69% match in meaning)
• CPAP Titration Using an Artificial Neural Network: A Randomized Controlled Study
  “Study was terminated due to lack of interest from subjects and no funding, only 1 subject signed consent but did not participate.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.